MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1.
about
Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterationsmiRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancersA loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability.MicroRNA‑20a promotes the proliferation and cell cycle of human osteosarcoma cells by suppressing early growth response 2 expression.Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinomaMicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancerOncogenic role of microRNA‑20a in human uveal melanoma.p21 participates in the regulation of anaplastic thyroid cancer cell proliferation by miR-146b.miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8.miR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB.The role of microRNAs in gallbladder cancer.Expression of MicroRNAs in Thyroid Carcinoma.Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.Down-regulation of miR-20a-5p triggers cell apoptosis to facilitate mycobacterial clearance through targeting JNK2 in human macrophages.Genistein up-regulates miR-20a to disrupt spermatogenesis via targeting Limk1.Low-Dose Endothelial-Monocyte-Activating Polypeptide-II Induced Autophagy by Down-Regulating miR-20a in U-87 and U-251 Glioma Cells.Restoration of miR-20a expression suppresses cell proliferation, migration, and invasion in HepG2 cells.Oncogenic role of microRNA-20a in human multiple myeloma.Expression, regulation and mechanism of action of the miR-17-92 cluster in tumor cells (Review).MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1.Clinical evaluation of circulating miR-548a-3p and -20a expression in malignant pleural mesothelioma patients.
P2860
Q27027491-D270075E-3799-41D8-AE1C-48B14F3FE38AQ28078451-BB08F8A3-2574-4BA7-A123-683C7FE9C81DQ35983871-2FC1CC17-CBC8-42E7-9239-BADB8A9FF0DFQ36089883-0FE2398C-3FD6-42C9-B05B-2BCF60586703Q36261847-38FF7A59-FECE-4E6A-99E0-3B5EEC09F50CQ36738904-D89B09E9-1578-45FB-9BB4-5A7E14880140Q37082920-9C475E36-B290-44D9-98D0-85772F2EDEE3Q37205979-9FFB187F-1A35-4BCF-AA28-AA12C854B127Q37682842-27728C0A-B20A-4C12-9A24-CCE473DBC418Q38842690-62663B0B-94A3-4C4A-84BE-A22B12523E3AQ38872859-F6B54948-D234-4097-8FC9-D7FC9159A300Q39328260-6D97F34A-F482-47D0-8523-8EC47C145B35Q39934280-B6B8480C-261C-4C0C-8F88-0C9D5848A4A2Q40587166-997CF38C-B484-456D-A62E-64761F7C11F3Q41709243-669BDC27-B138-474E-8405-6A79069C168BQ41860362-E2787D98-7B81-49FC-AB9A-2FF39B815C5BQ42104559-4A8D81C5-B6A9-4E21-BD40-3332CACB23AEQ42360156-87361910-C0D0-468D-B575-76817DC91F67Q47102900-01BF78BD-BE88-4594-8485-7BFD5B008799Q47348795-AB68C15F-1DE6-4DFE-B05B-B93FA8CE7D10Q50102994-2EBB2332-55D7-4134-B661-B73F2A560754
P2860
MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1.
@ast
MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1.
@en
type
label
MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1.
@ast
MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1.
@en
prefLabel
MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1.
@ast
MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1.
@en
P2093
P2860
P1433
P1476
MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1.
@en
P2093
Electron Kebebew
Lisa Zhang
P2860
P304
P356
10.1371/JOURNAL.PONE.0096103
P407
P577
2014-05-23T00:00:00Z